Clinical Trial

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 8, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is a multicenter, prospective clinical study aimed at evaluating the efficacy and safety of Huaier Granule in postoperative adjuvant treatment of resectable pancreatic cancer
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-11; most recent amendment 2024-05-07.
Status change: Not Yet Recruiting → Recruiting 2024-05-07
Trial Details
NCT Number NCT06368063
Lead Sponsor Xi'an Jiaotong University
Collaborators: LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Conditions Pancreatic Cancer Resectable
Enrollment 642 participants
Start Date 2024-05-06
Primary Completion 2026-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2024-05-08